Jia Wei

3.3k total citations
118 papers, 2.3k citations indexed

About

Jia Wei is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jia Wei has authored 118 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 37 papers in Oncology and 27 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jia Wei's work include Lung Cancer Treatments and Mutations (14 papers), Gastric Cancer Management and Outcomes (9 papers) and Immunotherapy and Immune Responses (9 papers). Jia Wei is often cited by papers focused on Lung Cancer Treatments and Mutations (14 papers), Gastric Cancer Management and Outcomes (9 papers) and Immunotherapy and Immune Responses (9 papers). Jia Wei collaborates with scholars based in China, United States and Spain. Jia Wei's co-authors include Jian He, Xiujian Chou, Jun‐Dong Cho, Jiliang Mu, Sujay Singh, Zhengyun Zou, Chun Wu, Yu Fan, Shuo Qian and Jing Zhang and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Jia Wei

112 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jia Wei China 28 817 566 427 409 361 118 2.3k
Hexige Saiyin China 28 1.2k 1.4× 328 0.6× 256 0.6× 311 0.8× 117 0.3× 82 2.1k
Abbas Ebrahimi‐Kalan Iran 17 762 0.9× 565 1.0× 424 1.0× 395 1.0× 173 0.5× 69 2.1k
Antonella Calogero Italy 29 1.4k 1.7× 499 0.9× 263 0.6× 343 0.8× 166 0.5× 84 2.6k
Chia‐Cheng Chang United States 33 2.0k 2.5× 404 0.7× 382 0.9× 542 1.3× 135 0.4× 128 4.0k
Bing Zou China 29 1.2k 1.5× 563 1.0× 158 0.4× 359 0.9× 231 0.6× 117 2.5k
Yonghyun Kim South Korea 31 889 1.1× 479 0.8× 430 1.0× 255 0.6× 385 1.1× 143 2.9k
Michele Cilli Italy 37 2.0k 2.5× 933 1.6× 439 1.0× 658 1.6× 280 0.8× 108 4.0k
Tokuhiro Chano Japan 31 1.4k 1.7× 498 0.9× 170 0.4× 542 1.3× 403 1.1× 108 2.7k
Xuan Liu China 30 1.6k 2.0× 514 0.9× 497 1.2× 652 1.6× 206 0.6× 110 2.8k

Countries citing papers authored by Jia Wei

Since Specialization
Citations

This map shows the geographic impact of Jia Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jia Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jia Wei more than expected).

Fields of papers citing papers by Jia Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jia Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jia Wei. The network helps show where Jia Wei may publish in the future.

Co-authorship network of co-authors of Jia Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Jia Wei. A scholar is included among the top collaborators of Jia Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jia Wei. Jia Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Fan, et al.. (2025). Joint control of multiple food processing contaminants in Maillard reaction: A comprehensive review of health risks and prevention. Comprehensive Reviews in Food Science and Food Safety. 24(2). e70138–e70138. 8 indexed citations
2.
Liu, Shuangqing, Junlin Wang, Jia Wei, et al.. (2025). Prediction and Validation of New Targets of NNPCN in Inhibiting Rhizoctonia Solani Based on Molecular Docking, Dynamics, and Biotechnology. Journal of Agricultural and Food Chemistry. 73(5). 2853–2864. 1 indexed citations
3.
Feng, Xin, Bowen Jiang, Chu‐Xiao Liu, et al.. (2025). Circular RNA aptamers targeting neuroinflammation ameliorate Alzheimer disease phenotypes in mouse models. Nature Biotechnology. 44(3). 454–463. 10 indexed citations
4.
Sun, Yunyan, Jinyan Liu, Dong Zhan, et al.. (2024). Depletion of Tregs from CD4+CAR‐T cells enhances the tumoricidal effect of CD8+CAR‐T cells in anti‐CD19 CAR‐T therapy. FEBS Journal. 292(8). 1904–1919. 2 indexed citations
5.
Zhang, Rui, et al.. (2024). miR‐34a promotes the immunosuppressive function of multiple myeloma‐associated macrophages by dampening the TLR‐9 signaling. Cancer Medicine. 13(11). e7387–e7387. 2 indexed citations
6.
Tian, Xuan, Jill Abrigo, Bonnie Lam, et al.. (2024). More severe cerebral small vessel disease associated with poor leptomeningeal collaterals in symptomatic intracranial atherosclerotic stenosis. Journal of Cerebral Blood Flow & Metabolism. 45(4). 655–663.
9.
Chen, Yun, et al.. (2021). Effects of machine transplanting density and panicle nitrogen fertilizer reduction on grains starch synthesis in good taste rice cultivars. ACTA AGRONOMICA SINICA. 47(8). 1540–1550. 1 indexed citations
11.
12.
Cao, Xiaodan, Haijun Yu, Chao Chen, Jia Wei, & Ping Wang. (2015). Expression and characterization of recombinant humanized anti-HER2 single-chain antibody in Pichia pastoris for targeted cancer therapy. Biotechnology Letters. 37(7). 1347–1354. 10 indexed citations
13.
Huang, Wei, Jie Liu, Xiangling Feng, et al.. (2015). DLC-1 induces mitochondrial apoptosis and epithelial mesenchymal transition arrest in nasopharyngeal carcinoma by targeting EGFR/Akt/NF-κB pathway. Medical Oncology. 32(4). 115–115. 26 indexed citations
14.
Costa, Carlota, Miguel Angel Molina, Ana Drozdowskyj, et al.. (2014). The Impact of EGFR T790M Mutations and BIM mRNA Expression on Outcome in Patients with EGFR -Mutant NSCLC Treated with Erlotinib or Chemotherapy in the Randomized Phase III EURTAC Trial. Clinical Cancer Research. 20(7). 2001–2010. 180 indexed citations
15.
Zou, Zhengyun, Jia Wei, Xiaolin Li, et al.. (2012). Enhancement of Anticancer Efficacy of Chemotherapeutics by Gambogic Acid Against Gastric Cancer Cells. Cancer Biotherapy and Radiopharmaceuticals. 27(5). 299–306. 16 indexed citations
16.
Li, Weidong, Fangfang Liu, Ting Lei, et al.. (2010). The clinicopathological significance of CD44+/CD24−/low and CD24+ tumor cells in invasive micropapillary carcinoma of the breast. Pathology - Research and Practice. 206(12). 828–834. 27 indexed citations
17.
Su, Rongjian, Zhen Li, Hongdan Li, et al.. (2010). Grp78 promotes the invasion of hepatocellular carcinoma. BMC Cancer. 10(1). 20–20. 85 indexed citations
18.
Fernández-Sainz, I., Lauren G. Holinka, Boris Gavrilov, et al.. (2009). Alteration of the N-linked glycosylation condition in E1 glycoprotein of Classical Swine Fever Virus strain Brescia alters virulence in swine. Virology. 386(1). 210–216. 25 indexed citations
19.
Liu, Fangfang, et al.. (2008). [Significance of expression of stromal cell derived factor 1 and CXCR4 in invasive breast cancer].. PubMed. 37(8). 529–35. 3 indexed citations
20.
Liu, Xuesong, Yong Zhu, Yingna Li, et al.. (2003). Preparation and Characterization of a Set of Monoclonal Antibodies to TRAIL and TRAIL Receptors DR4, DR5, DcR1, and DcR2. PubMed. 22(2). 121–125. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026